134 related articles for article (PubMed ID: 33410622)
1. Treatment of liver metastases in patients with epithelial ovarian cancer.
Deng H; Zhu HL; Li Y; Wang Y; Wu Y; Cui H; Wang JL; Li XP
Chin Med J (Engl); 2021 Jan; 134(10):1236-1238. PubMed ID: 33410622
[No Abstract] [Full Text] [Related]
2. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
Wang B; Wang S; Ren W
BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
[TBL] [Abstract][Full Text] [Related]
3. State of the art of surgery in advanced epithelial ovarian cancer.
Hacker NF
Ann Oncol; 2013 Dec; 24 Suppl 10():x27-32. PubMed ID: 24265399
[No Abstract] [Full Text] [Related]
4. Ovarian cancer metastases in the liver area: proposal of a standardized anatomo-surgical classification.
Rosati A; De Rose AM; Sala E; Giuliante F; Scambia G; Fagotti A
Int J Gynecol Cancer; 2022 Jul; 32(7):955-956. PubMed ID: 35428689
[No Abstract] [Full Text] [Related]
5. The evolving role of cytopathology in the era of neoadjuvant chemotherapy for the accurate pathologic diagnosis of epithelial ovarian cancer.
Everett EN
Cancer Cytopathol; 2017 Oct; 125(10):743-744. PubMed ID: 28759154
[No Abstract] [Full Text] [Related]
6. Intraoperative rupture and chemotherapy use in stage I ovarian cancer.
Matsuo K; Rau AR; Machida H; Roman LD; Wright JD
Eur J Obstet Gynecol Reprod Biol; 2023 May; 284():200-202. PubMed ID: 36948943
[No Abstract] [Full Text] [Related]
7. [Bone and liver metastases in uterine, cervical and ovarian cancer].
Karkavitsas N
Rontgenblatter; 1988 Aug; 41(8):326-8. PubMed ID: 3217713
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy for ovarian cancer: Avoiding 'needless hurt'?
Morrison J
BJOG; 2023 Dec; 130(13):1589-1590. PubMed ID: 37518947
[No Abstract] [Full Text] [Related]
9. Utility of radionuclide liver/spleen scanning and serum enzyme level in detecting hepatic metastases from ovarian carcinoma.
Mettler FA; Christie JH; Crow NE; Garcia JF; Wicks JD; Bartow SA
Cancer; 1982 Sep; 50(5):909-11. PubMed ID: 7093929
[TBL] [Abstract][Full Text] [Related]
10. [Effect of evidence-based medicine on the decision of chemotherapy for epithelial ovarian cancer].
Li GT
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):582-6. PubMed ID: 23141177
[No Abstract] [Full Text] [Related]
11. Surgical staging of early stage epithelial ovarian cancer.
Huntsman DG; Gilks CB
Gynecol Oncol; 2011 Aug; 122(2):460-1; author reply 461-2. PubMed ID: 21531012
[No Abstract] [Full Text] [Related]
12. Novel directions in adjuvant chemotherapy for early stage epithelial ovarian cancer.
Sakarya DK; Yetimalar MH; Ozbasar D
Asian Pac J Cancer Prev; 2015; 16(10):4157-60. PubMed ID: 26028065
[TBL] [Abstract][Full Text] [Related]
13. Oregovomab Plus Chemo in Newly Diagnosed Patients with Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery (FLORA-5/GOG-3035).
Gregory SN; Sarvestani AL; Ryan CE; Teke ME; Akmal SR; Hernandez JM; Gupta S
Ann Surg Oncol; 2023 Mar; 30(3):1299-1301. PubMed ID: 36400892
[No Abstract] [Full Text] [Related]
14. Subtypes of stage IV ovarian cancer; response to treatment and patterns of disease recurrence.
Jamieson A; Sykes P; Eva L; Bergzoll C; Simcock B
Gynecol Oncol; 2017 Aug; 146(2):273-278. PubMed ID: 28549816
[TBL] [Abstract][Full Text] [Related]
15. [Surgery in early-stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
Bolze PA; Collinet P; Golfier F; Bourgin C
Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):168-179. PubMed ID: 30686727
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy fails to improve survival in advanced ovarian cancer: but is it the real culprit?
Di Giorgio A; Sammartino P; Biacchi D
Int J Gynecol Cancer; 2011 May; 21(4):596. PubMed ID: 21543925
[No Abstract] [Full Text] [Related]
17. Role of chemotherapy in epithelial ovarian cancer.
Markman M
Minerva Ginecol; 2011 Jun; 63(3):287-97. PubMed ID: 21654613
[TBL] [Abstract][Full Text] [Related]
18. Pattern of recurrence after interval cytoreductive surgery and HIPEC following neoadjuvant chemotherapy in primary advanced stage IIIC/IVA epithelial ovarian cancer.
Sinukumar S; Damodaran D; Ray M; Mehta S; Paul L; Bhatt A
Eur J Surg Oncol; 2021 Jun; 47(6):1427-1433. PubMed ID: 33509612
[TBL] [Abstract][Full Text] [Related]
19. The omentum and omentectomy in epithelial ovarian cancer: a reappraisal: part II--The role of omentectomy in the staging and treatment of apparent early stage epithelial ovarian cancer.
Arie AB; McNally L; Kapp DS; Teng NN
Gynecol Oncol; 2013 Dec; 131(3):784-90. PubMed ID: 24056005
[TBL] [Abstract][Full Text] [Related]
20. Regression of liver metastases after high-dose chemotherapy and peripheral-blood progenitor-cell support in Stage IV ovarian cancer.
Yamashiro C; Yanagihara T; Hata T
Int J Gynaecol Obstet; 2000 Dec; 71(3):245-8. PubMed ID: 11102614
[No Abstract] [Full Text] [Related]
[Next] [New Search]
